Cargando…

Cellular fibronectin in serum and plasma: a potential new tumour marker?

The concentration of cellular fibronectin (cFN) containing the extra domain A (EDA) was measured in 479 plasma and 300 serum samples from healthy blood donors by a competitive enzyme immunoassay (EIA). Serum and plasma samples contained low concentrations of EDAcFN. The mean concentration of EDAcFN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ylätupa, S., Haglund, C., Mertaniemi, P., Vahtera, E., Partanen, P.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033647/ https://www.ncbi.nlm.nih.gov/pubmed/7880741

Ejemplares similares

Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA.
por: Haglund, C., et al.
Publicado: (1997)

Plasma and Cellular Forms of Fibronectin as Prognostic Markers in Sepsis
por: Lemańska-Perek, Anna, et al.
Publicado: (2020)

Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
por: Pasanen, P. A., et al.
Publicado: (1992)

Fibroblast cellular and plasma fibronectins are similar but not identical
Publicado: (1979)

Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.
por: Haglund, C., et al.
Publicado: (1986)

Keloid Pathogenesis: Potential Role of Cellular Fibronectin with the EDA Domain
por: Andrews, Jonathan P., et al.
Publicado: (2015)

Co-assembly of plasma and cellular fibronectins into fibrils in human fibroblast cultures
Publicado: (1990)

Plasma and cellular fibronectin: distinct and independent functions during tissue repair
por: To, Wing S, et al.
Publicado: (2011)

Circulating immunoreactive and bioassayable opsonic plasma fibronectin during experimental tumour growth
por: Saba, T. M., et al.
Publicado: (1980)

Oncofoetal fibronectin – a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma
por: Hesse, E, et al.
Publicado: (2005)

Labeling on a Chip of Cellular Fibronectin and Matrix Metallopeptidase-9 in Human Serum
por: Prabowo, Briliant Adhi, et al.
Publicado: (2022)

Colonial morphology of tumour cells and susceptibility to cytolysis by tumour necrosis factor. The role of cellular fibronectin deposition in the extracellular matrix.
por: Neale, M. L., et al.
Publicado: (1990)

Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
por: Kuusela, P., et al.
Publicado: (1987)

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
por: Haglund, C., et al.
Publicado: (1994)

Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
por: Kuusela, P., et al.
Publicado: (1991)

Plasma Fibronectin. Structure and Function
por: Lockwood, Charles J.
Publicado: (1987)

Changes of plasma fibronectin and fibronectin-fibrin complexes in dams of stillborn dairy calves
por: Jawor, Paulina, et al.
Publicado: (2020)

The alternatively spliced V region contributes to the differential incorporation of plasma and cellular fibronectins into fibrin clots
Publicado: (1992)

Changes in Plasma von Willebrand Factor and Cellular Fibronectin in MRI-Defined Traumatic Microvascular Injury
por: Sandsmark, Danielle K., et al.
Publicado: (2019)

Cellular origin of fibronectin in interspecies hybrid kidneys
Publicado: (1984)

Shaping Up the Tumor Microenvironment With Cellular Fibronectin
por: Efthymiou, Georgios, et al.
Publicado: (2020)

Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
por: Haglund, C.
Publicado: (1986)

Serum Metallothioneins in Childhood Tumours—A Potential Prognostic Marker
por: Kruseova, Jarmila, et al.
Publicado: (2013)

Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
por: Haglund, C., et al.
Publicado: (1991)

Distribution of fetal bovine serum fibronectin and endogenous rat cell fibronectin in extracellular matrix
Publicado: (1979)

A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
por: Pasanen, P. A., et al.
Publicado: (1994)

Plasma and Peritoneal Fluid Fibronectin and Collagen IV Levels as Potential Biomarkers of Endometriosis
por: Warzecha, Damian, et al.
Publicado: (2022)

Serum proteins as tumour markers for breast cancer.
por: Mattison, P., et al.
Publicado: (1981)

Analysis of Soluble Molecular Fibronectin-Fibrin Complexes and EDA-Fibronectin Concentration in Plasma of Patients with Atherosclerosis
por: Lemańska-Perek, Anna, et al.
Publicado: (2016)

Role of fibronectin in the migration of fibroblasts into plasma clots
Publicado: (1986)

Solution and surface effects on plasma fibronectin structure
Publicado: (1983)

Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer
por: Kujawa, Katarzyna Aleksandra, et al.
Publicado: (2020)

A serum factor with potential as a tumour marker in malignant lymphoma.
por: Begent, R. H., et al.
Publicado: (1980)

Laminin and fibronectin in rectal adenocarcinoma: relationship to tumour grade, stage and metastasis.
por: Forster, S. J., et al.
Publicado: (1984)

Frequency of serum tumour marker monitoring.
por: Colls, B. M.
Publicado: (1991)

Fibronectin-plasma membrane interaction in the adhesion of hemopoietic cells
Publicado: (1986)

Human plasma fibronectin promotes proliferation and differentiation of odontoblast
por: TANG, Jia, et al.
Publicado: (2017)

Serum fibronectin distinguishes the early stages of hepatocellular carcinoma
por: Kim, Hyunsoo, et al.
Publicado: (2017)

The evolution of tenascins and fibronectin
por: Adams, Josephine C, et al.
Publicado: (2015)

Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions.
por: Natali, P. G., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_g1k10gfiejhlusfinjbk8mgc85